NODO refers to life-threatening overdose of a drug or combination of drugs not in the family of opioids - this means a mu-receptor antagonist like naloxone will not reverse this toxicity. Most NODO lack a specific antidote, presenting a considerable unmet medical need. An effective treatment for NODO would have significant potential for helping many patients with life-threatening toxicity - an all too common problem.
LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA. LipidRescue® is a proposed proprietary name that is subject to FDA approval.
LipidRescue® can potentially reverse toxicity caused by a wide range of drugs, including several drugs involved in severe, or even fatal NODO. The mechanism is widely applicable and can apply to combinations of drugs and situations where the offending drugs are unknown.
LipidRescue® is an investigational drug; the safety and efficacy of the drug have not been approved or authorized by FDA.
LipidRescue® is a proposed proprietary name that is subject to FDA approval.
Website designed by JDW
Copyright © 2021 ResQ Pharma, Inc - All Rights Reserved.
Powered by GoDaddy